Skip to main content
SpringerLink
Log in

Traitement chirurgical du cancer du sein

  • Chapter
Le cancer du sein

Part of the book series: Oncologie pratique ((ONCOLPRAT))

  • 555 Accesses

Abstrait

La chirurgie est la méthode la plus ancienne pour obtenir le contrôle local du cancer du sein. Historiquement privilège des barbiers, le traitement faisait appel à des applications locales de produits divers à ľefficacité douteuse. Des applications de fer rouge furent faites à la reine Anne ďAutriche! Les tumeurs du sein étaient bien connues des anciens auteurs, ľengorgement des ganglions axillaires satellites également, mais c’est à Halsted que ľon doit en 1898 la première description ďune série ďamputations du sein avec un contrôle postopértoire satisfaisant. Ľâge de la chirurgie du sein était né et cette intervention de Halsted a subi de multiples variations au fil du temps jusqu’aux années 1950 où le traitement conservateur apparut associé à la radiothérapie postopératoire.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Clough KB, Heitz D, Salmon RJ (2003). Chirurgie loco-régionale des cancers du sein. Encycl Méd Chir (Elsevier SAS, Paris, tous droits réservés), Techniques chirurgicales-Gynécologie, 41–970, 15p

    Google Scholar 

  2. Sappey C PH (1874) Anatomie, physiologie, pathologie des Vaisseaux Lymphatiques. Adrien Delahaye Librairie Éditeur, Paris

    Google Scholar 

  3. Berg JW (1955) The significance of axillary node levels in the study of breast carcinoma. Cancer, 8: 776–8

    Article  PubMed  CAS  Google Scholar 

  4. Vrdoljak DV, Ramjlak V, Muzina D et al. (2005) Analysis of metastactic involvement of interpectoral (Rotter’s) lymph nodes related to tumor location, size, grade and hormone receptor status in breast cancer. Tumori, 91: 177–81

    PubMed  Google Scholar 

  5. Grossman F (1896) Uber die axillaren lynphdrusen: Inaugural dissertation. Berlin, Germany

    Google Scholar 

  6. Rotter J (1899) Zur topographie des Mamma-carcinoma. Arch Klinische Chirurgie 58: 346–56

    Google Scholar 

  7. Halsted WS (1907) The results of radical operations for the cure of carcinoma of the breast. Ann Surg 46: 1–10

    PubMed  CAS  Google Scholar 

  8. Patey DH, Dyson WH (1948) The prognosis of carcinoma of the breast in relation to the type of operation performed. Br J Cancer 27–13

    Google Scholar 

  9. Madden Jl, Kandalaft S, Bouraque RA (1972) Modified mastectomy. Ann Surg. 175: 624–34

    Article  PubMed  CAS  Google Scholar 

  10. Tailhefer A (1961) Pronostic et traitement chirurgical et radiochirurgical des cancer du sein. Ann Chir 15: 403–15

    PubMed  CAS  Google Scholar 

  11. Vilcocq JR et al. (1981) The outcome of treatment by tumorectomy and radiotherapy of patients with operable breast cancer. Int J Radiat Oncol Biol Phys 7: 1327–32

    Google Scholar 

  12. Veronesi U, Saccozzi, Del Vecchio et al. (1981) Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med 305: 6–11

    PubMed  CAS  Google Scholar 

  13. Salmon RJ, Ansquer Y, Asselain B (1998) Preservation versus section of intercostalbrachial nerve (IBN) in axillary dissection for breast cancer — a prospective randomized trial. Eur Surg Oncol 24: 158–61

    Article  CAS  Google Scholar 

  14. Krag DN, Weaver DL, Alex JC, Fairbank JT (1993) Surgical resection and radiolocalization of sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2: 335–340

    Article  PubMed  CAS  Google Scholar 

  15. Giuliano AE, Kirgan DM, Guenther JM et al. (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220: 391–8

    Article  PubMed  CAS  Google Scholar 

  16. Veronesi U, Paganelli G, Galimberti V et al. (1997) Sentinelnode biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349: 1864–7

    Article  PubMed  CAS  Google Scholar 

  17. Arnaud S, Houvenaeghel G, Guiramand J et al. (2004) Patients’ and surgeons’ perspectives on axillary surgery for breast cancer. Eur J Surg Oncol 30: 735–43

    Article  PubMed  CAS  Google Scholar 

  18. Nos C, Freneaux P, Guilbert S et al. (2001) Sentinel lymph node detection for breast cancer: which patients are best suited for the patent blue dye only method of identification? Ann Surg Oncol 8: 438–43

    Article  PubMed  CAS  Google Scholar 

  19. Salmon RJ, Nos C, Lojodice F et al. (2000) Sentinel node and operable breast cancer: utilization of blue dye injection. Pilot study. Ann Chir 125: 253–8

    Article  PubMed  CAS  Google Scholar 

  20. Freneaux P, Nos C, Vincent-Salomon A et al. (2002) Histological detection of minimal metastatic involvement in axillary sentinel nodes: a rational basis for a sensitive methodology usable in daily practice. Mod Pathol 15: 641–6

    Article  PubMed  Google Scholar 

  21. Green FL, Page DL, Fleming ID et al. (2002) AJCCC Cancer staging Manuel (ed 6). New York, Springer, NY

    Google Scholar 

  22. Singletary SE, Greene FL, Sobin L et al. (2003) Classification of Isolated Tumor Cells. Cancer 98: 2740–41

    Article  PubMed  Google Scholar 

  23. Van Zee KJ, Manasseh D, Bevilacqua J et al. (2003) A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel lymph node biopsy. Annals of Surg Oncol 10: 1140–51

    Article  Google Scholar 

  24. Recommendations pour la pratique clinique de Saint-Paul-deVence (2005) Oncologie 7: 342–79

    Article  Google Scholar 

  25. Lyman GH, Giuliano E, Somerfield MR et al. (2000) American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer. J Clin Oncol 23: 7703–20

    Article  Google Scholar 

  26. Mansel R. After Mapping of the Axilla: Radiotherapy or Surgery AMAROS: EORTC 10981–22023. [Available from: http://www.ncrn.org.uk/portfolio/data.asp?ID=1424]

    Google Scholar 

  27. Giuliano A. American College of surgeons Oncology Group. ACOSOG-Z0011. A randomized trial of axillary node dissection in women with clinical T1 or T2 N0 M0 breast cancer who have a positive sentinel node; 2004. [available from: yttp://www. acosog.org/studies/organ site/breast/index.jsp]

    Google Scholar 

  28. Galimberti V (2004) International Breast Cancer Study Group (IBCSG)—Trial 23-01. Phase iii randomized study of surgical resection with or without axillary lymph node dissection in women with clinically node-negative breast cancer with sentinel node micrometastasis; [Available from: http://cancer.gov/clinicaltrials/IBCSG-23-01]

    Google Scholar 

  29. Alran S, De Rycke Y, Salmon RJ et al. (2007) Validation and limitations of use of a Breast Cancer Nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy. Ann Surg Oncol Feb 9 [Epub ahaed of print]

    Google Scholar 

  30. Dowlatshahi K, Fan M, Snider H, Habib F (1997) Lymph node micrometastases from breast carcinoma. Cancer 80: 1188–97

    Article  PubMed  CAS  Google Scholar 

  31. Langer I, Marti RM, Guller U et al. (2005) Axillary recurrence rate in breast cancer patients with negative sentinel lymph node or SLN micrometastases. Annals of Surgery 241: 152–8

    PubMed  Google Scholar 

  32. Chapgar A, Middleton L, Sahin et al. (2005) Clinical outcome of patients with lymph node-negative breast carcinoma who have SLN micrometastases detected by immuinohistochemistry. Cancer 103: 1581–6

    Article  Google Scholar 

  33. Colleoni M, Rotmensz N, Peruzzotti G et al. (2005) Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol 23: 1379–89

    Article  PubMed  Google Scholar 

  34. Bleiweiss IJ, Chadandeep SN Jaffer S (2006) Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma. J Clin Oncol 24: 2013–8

    Article  PubMed  Google Scholar 

  35. Mamounas EP, Brown S et al. (2005) Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 23: 2694–702

    Article  PubMed  Google Scholar 

  36. Haigh Pl, Hansen NM, Qi K et al. (2000) Biopsy method excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol 7: 21–7

    Article  PubMed  CAS  Google Scholar 

  37. Aihara T, Munakata S, Morino H, Takatsuka Y (2004) Feasibility of sentinel node biopsy for breast cancer after neoadjuvant endocrine therapy: a pilot study. J Surg Oncol. 85: 77–81

    Article  PubMed  Google Scholar 

  38. Purushotham AD, Upponi S, Klevesath MB et al. (2005) Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol. 23: 4312–21.

    Article  PubMed  Google Scholar 

  39. Mansel RE, Fallowfield L, Kissin M et al. (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98: 599–609

    Article  PubMed  Google Scholar 

  40. Groupe ďétude des cancers du sein de ľInstitut Curie (Brigitte Sigal-Zafrani, coordinatrice). Institut Curie-Référentiels de traitement des cancers du sein-Mise à Jour 2005

    Google Scholar 

  41. Pocard M, Pouillart P, Asselain B, Salmon RJ (2000) Hepatic resection in metastatic breast cancer: results and prognostic factors. Eur. J Surg Oncol 26: 155–9

    Article  PubMed  CAS  Google Scholar 

  42. Sigal-Zafrani B, Muller K, El Khoury C. et al. (2007) Vacuum-assisted large core needle biopsy improves the management of patients with breast microcalcification: analysis of 1009 cases. In Submission in Eur J Surg Oncol

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut Curie, 26, rue ďUlm, 75005, Paris

    S. Alran & R. Salmon

Authors
  1. S. Alran
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Salmon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag France

About this chapter

Cite this chapter

Alran, S., Salmon, R. (2007). Traitement chirurgical du cancer du sein. In: Le cancer du sein. Oncologie pratique. Springer, Paris. https://doi.org/10.1007/978-2-287-36073-2_5

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-36073-2_5

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-36071-8

  • Online ISBN: 978-2-287-36073-2

Publish with us

Policies and ethics

Search

Navigation